Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Vrielink

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Opinion in Hematology|November 14, 1998
Transfusion-transmissible infectionsH Vrielink, H W Reesink
Vox Sanguinis|October 16, 2010
Preparation of granulocyte concentrates by apheresis: situation in the NetherlandsH Vrielink, M M W Koopman
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 15, 2025
Findings in the Immuno-hematology workshop during the International Congress of the WAA 2024 in IndonesiaA M E Sundermeijer, H Vrielink
Vox Sanguinis|March 21, 2002
Early detection of hepatitis B surface antigen and detection of HBsAg mutants: a comparison of five assaysH L Zaaijer, H Vrielink, M Koot
Transfusion Medicine Reviews|July 1, 1997
The clinical relevance of HTLV type I and II in transfusion medicineH Vrielink, H L Zaaijer, H W Reesink
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 2, 2013
One week education in apheresis at Dharmais National Cancer HospitalB Eka, H Vrielink, Y Lubis, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 2, 2013
Plasmapheresis and clotting activationH Vrielink, W Karssing, D de Korte, et al.
Vox Sanguinis|January 1, 1995
Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodiesH Vrielink, C L van der Poel, H W Reesink
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 12, 2021
Taking therapeutic apheresis services to patients in South Africa: An eight year review of SANBS mobile therapeutic apheresis service, 2013-2020C Poole, C Strydom, K van der Berg, et al.
Vox Sanguinis|August 15, 1998
Donor selection: the exclusion of high risk donors?P J van den Burg, H Vrielink, H W Reesink
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Opinion in Hematology|November 14, 1998
Transfusion-transmissible infectionsH Vrielink, H W Reesink
Vox Sanguinis|October 16, 2010
Preparation of granulocyte concentrates by apheresis: situation in the NetherlandsH Vrielink, M M W Koopman
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 15, 2025
Findings in the Immuno-hematology workshop during the International Congress of the WAA 2024 in IndonesiaA M E Sundermeijer, H Vrielink
Vox Sanguinis|March 21, 2002
Early detection of hepatitis B surface antigen and detection of HBsAg mutants: a comparison of five assaysH L Zaaijer, H Vrielink, M Koot
Transfusion Medicine Reviews|July 1, 1997
The clinical relevance of HTLV type I and II in transfusion medicineH Vrielink, H L Zaaijer, H W Reesink
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 2, 2013
One week education in apheresis at Dharmais National Cancer HospitalB Eka, H Vrielink, Y Lubis, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 2, 2013
Plasmapheresis and clotting activationH Vrielink, W Karssing, D de Korte, et al.
Vox Sanguinis|January 1, 1995
Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodiesH Vrielink, C L van der Poel, H W Reesink
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 12, 2021
Taking therapeutic apheresis services to patients in South Africa: An eight year review of SANBS mobile therapeutic apheresis service, 2013-2020C Poole, C Strydom, K van der Berg, et al.
Vox Sanguinis|August 15, 1998
Donor selection: the exclusion of high risk donors?P J van den Burg, H Vrielink, H W Reesink
Pageof 5